PADI2 and breast cancer: Inhibition of PAD2 expression in breast cancer (MCF-7 cells) significantly decreased cell migration ability but did not affect cell proliferation and apoptosis [106], while use of Cl-amidine in MCF-7 cells reduced EV release and sensitised MCF-7cells to chemotherapy [12].